4//SEC Filing
Pfeil Keith W 4
Accession 0001209191-23-007323
CIK 0001237831other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:52 PM ET
Size
13.0 KB
Accession
0001209191-23-007323
Insider Transaction Report
Form 4
Pfeil Keith W
DirectorPresident, CEO
Transactions
- Sale
Class A Common Stock
2023-02-02$77.57/sh−29,167$2,262,426→ 0 total - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2023-02-02−14,167→ 5,833 totalExercise: $49.65Exp: 2029-09-03→ Class A Common Stock (14,167 underlying) - Exercise/Conversion
Class A Common Stock
2023-02-02$49.65/sh+14,167$703,392→ 14,167 total - Exercise/Conversion
Class A Common Stock
2023-02-02$53.27/sh+15,000$799,050→ 29,167 total - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2023-02-02−15,000→ 9,167 totalExercise: $53.27Exp: 2030-01-22→ Class A Common Stock (15,000 underlying)
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $77.885, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]These options were granted on September 3, 2019 and are fully vested.
- [F4]These options were granted on January 22, 2020 and are fully vested.
Documents
Issuer
GLOBUS MEDICAL INC
CIK 0001237831
Entity typeother
Related Parties
1- filerCIK 0001752014
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 4:52 PM ET
- Size
- 13.0 KB